| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_c825e809360f43fc70ca9e22d94cce44
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_42d6d7150234776105645d46b8a89e25
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_f70f160f5fc0cb89f13a21f8dfc71c6e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_ee83146a4c616781cfbf8d33450630ad |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61L15-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61L15-48 |
| filingDate |
2000-11-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2003-05-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4f9542d1fa802097828eb1267fed424f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7fc8559bec74efe721777f16eb029eb7
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0eb5e92ca9b024f7fa92b44879d4e19e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f444172239357268a9459afe7fe5176e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_816c197f22ef6cb3f17925d2a19cbdd3
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ac764135afb7c7f852e2371f75bb8b8e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c3d441424358c45965098a7b90f8907a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_819dc80ee254debe4f81ba2b845245f4
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a62a88fa8993a65f6d5ed612576ea1bb
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e0ed775c5e99d6a8b6ec8d6e31071d82
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4f95af930a023a2a644eae59cf0149a2 |
| publicationDate |
2003-05-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
RU-2203684-C2 |
| titleOfInvention |
Method for obtaining bandage material |
| abstract |
FIELD: medicine. SUBSTANCE: the innovation deals with obtaining bandage materials for treating purulentnecrotic wounds of different etiology. Bandage material contains, simultaneously, trypsin proteolytic enzyme and antioxidants with different physical properties: dieton and mexidol. The former is water-insoluble and it is immobilized out of dimethysulfoxide solution. At the second stage trypsin should be chemically combined with carrier (dialdehydecellulose). At the third stage material should be impregnated with mexidol solution. At applying a napkin made of such a material mexidol enters wound secrete, maintenance dose of difficultly soluble dieton enters the wound for the prolonged period of time. Trypsin purifies the wound against detritus due to covalent addition during the whole period of napkin's application (up to 72 h). Curative effect at applying trypsincontaining bandage material along with two different antioxidants increases by 1.5 times the effect obtained at applying trypsin and dieton only or trypsin and mexidol only. EFFECT: higher efficiency. 1 cl, 1 tbl |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2011160862-A1 |
| priorityDate |
2000-11-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |